Efficient cancer therapy with a nanobody-based conjugate.
Cortez-Retamozo V, Backmann N, Senter PD, Wernery U, De Baetselier P, Muyldermans S, Revets H.
Cortez-Retamozo V, et al.
Cancer Res. 2004 Apr 15;64(8):2853-7. doi: 10.1158/0008-5472.can-03-3935.
Cancer Res. 2004.
PMID: 15087403
In vitro experiments showed that the nanobody-enzyme conjugate effectively activated the release of phenylenediamine mustard from the cephalosporin nitrogen mustard prodrug 7-(4-carboxybutanamido) cephalosporin mustard at the surface of carcinoembryonic antigen-expr …
In vitro experiments showed that the nanobody-enzyme conjugate effectively activated the release of phenylenediamine mustard f …